Key Responsibilities:

• Provide scientific and technical insights, contribute to the clinical study biomarker strategy and plan to enable proof of mechanism, proof of biology, safety and efficacy understanding and patient selection.
• Lead the definition and implementation of soluble biomarker strategy and investments to cover biomarker needs and gaps in early and late projects
• Build “state of the art technical” capability in the group by leading the identification and evolution of innovative technical solutions.
• In partnership with therapeutic area heads and clinical teams set priorities and allocate resources to maximize soluble biomarker impact in clinical studies
• Partner with outsourcing functions to define and implement soluble biomarker outsourcing strategy to maximize the deliverables of internal resources
• Lead and grow the global group by attracting, retaining, and developing talents.
• Build partnerships and alliances with external academics, innovative companies, technology partners that can be leveraged to aid in the mission of the group.
• Provide scientific and organizational leadership for capability building, including annual portfolio reviews, workshops, and retrospectives. Drives the Biomarker Development “One BMD” vision and mission by evaluating emerging trends, technologies, and partnerships.
• Contribute to Translational Medicine and Biomedical Research strategic initiatives and represent the group within the wider scientific community inside and outside of Novartis.

Essential Requirements:

• PhD in Biology, Biochemistry, Immunology or related field
• 10+ years industry experience of direct management and/or leadership in clinical biomarker bioanalytical field; preferably including some experience leading other people managers 
• Extensive experience in technical development, validation, and implementation of both LBA (e.g. MSD, Ella, NULISA, Olink) and LC-MS based soluble biomarker assays in clinical studies according to international guidelines
• Experience with soluble biomarker profiling platforms
• Understanding of regulatory requirement relevant to Biomarker Development (e.g. GCLP, ICH)
• Proven track record of building and leading high-performing teams. Prioritizes resources and develops talent in a diverse, global matrix organization.
• Outstanding ability to establish effective collaborative relationships with cross-functional scientific teams across an innovative, dynamic organization.
• Excellent interpersonal and communications skills, and ability to represent the group within Biomedical Research and throughout the wider scientific community internal or external to Novartis.
• Demonstrated organizational skills, aligning available resources to meet goals
• Good Computer skills for basic and bioanalytical tools

Novartis Compensation and Benefit Summary: The pay range for this position at commencement of employment is expected to be between: $185,500 and $344,500/year; however, while salary ranges are effective from 1/1/25 through 12/31/25, fluctuations in the job market may necessitate adjustments to pay ranges during this period.  Further, final pay determinations will depend on various factors, including, but not limited to geographical location, experience level, knowledge, skills, and abilities. The total compensation package for this position may also include other elements, including a sign-on bonus, restricted stock units, and discretionary awards in addition to a full range of medical, financial, and/or other benefits (including 401(k) eligibility and various paid time off benefits, such as vacation, sick time, and parental leave), dependent on the position offered. Details of participation in these benefit plans will be provided if an employee receives an offer of employment. If hired, employee will be in an “at-will position” and the Company reserves the right to modify base salary (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department/team performance, and market factors.